retatrutide fda approval status 2025 Timeline: Week-by-Week Results (48 Weeks) Retatrutide FDA Approval Status: July

After reconstitution, store the solution at 2-8C, protected from light, and use it within 30 days

These often feature: Stock video testimonials from patients Claims that injections are outdated Promises of painless, fast weight loss Fake headlines like FDA breakthrough now available over the counter These ads aim to capture impulse buyers with health concerns like obesity or diabetes

"Our approach emphasizes stewardship of the entire treatment continuum, from start through maintenance, with a clear clinical framework for when therapy can be safely reduced and, when appropriate, discontinued. Today, there is no clear standard for how long patients should stay on GLP-1s or how to safely come off

Starting with tirzepatide at conservative doses provides a safer entry point for this population

FDA safety concerns The FDA has been vocal about safety concerns regarding compounded GLP-1 medications

Dietary composition has been shown to influence endogenous GLP-1 secretion